QUAKERTOWN, PA — Microsize, a prominent provider of particle sizing services, has signed a long-term supply agreement with Cerus Corporation, the creator of the INTERCEPT® Blood System for Plasma. This partnership aims to enhance a pathogen inactivation technology that is instrumental in ensuring the safety of the global blood supply.
The INTERCEPT Blood System uses functional powders to deactivate pathogens in blood components, a critical process employed by blood centers worldwide. The collaboration with Microsize will allow Cerus to meet the growing demand for INTERCEPT-treated blood components including plasma and cryoprecipitate.
The supply agreement includes a joint capital expenditure (CAPEX) investment to build an additional dedicated manufacturing suite next year. It will also qualify a higher-throughput processing train to increase the production capability of these essential medical supplies.
“We are excited to meet the challenge presented to us by Cerus, our long-standing partner and a global leader in pathogen inactivation technology,” said TJ Higley, CEO of Microsize. “Our new larger manufacturing suite, with increased automation and a digital batch record, will add efficiencies and reliability into the supply chain planning process.”
Erik Bosman, Cerus’ vice president global supply chain, expressed his delight at the continuation of the relationship with Microsize. He praised the Microsize team for their expertise and their pivotal role in the development of Cerus’ pathogen inactivation system over the last two decades.
“We look forward to working together into the future,” Bosman said. “We are grateful to Microsize for helping us to execute on our mission to safeguard the global blood supply.”
Microsize’s high-throughput particle sizing services have been integral to the success of Cerus’ INTERCEPT Blood System. This renewed partnership and the planned expansion of manufacturing capabilities represent a significant step forward in improving the delivery and effectiveness of pathogen inactivation technology. This move is expected to have a substantial impact on the safety and reliability of the global blood supply.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.